SLB
56
-3
DVA
72
-3
QCOM
55
-2
ETR
68
-3
NTAP
61
-3
GOOGL
59
-8
OXY
55
6
ABT
57
-5
GOOG
69
-10
LB
63
-4
CVX
38
6
BA
45
-3
HSY
43
3
CMI
67
4
GIS
29
3
XEL
65
-2
HCP
70
-4
DOV
73
4
DVN
29
4
AES
41
2
SLB
56
-3
DVA
72
-3
QCOM
55
-2
ETR
68
-3
NTAP
61
-3
GOOGL
59
-8
OXY
55
6
ABT
57
-5
GOOG
69
-10
LB
63
-4
CVX
38
6
BA
45
-3
HSY
43
3
CMI
67
4
GIS
29
3
XEL
65
-2
HCP
70
-4
DOV
73
4
DVN
29
4
AES
41
2
Financhill
Back

Ocular Therapeutix Quote, Financials, Valuation and Earnings

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Buy
72

OCUL
Ocular Therapeutix

Last Price:
9.92
Seasonality Move:
38.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Ocular Therapeutix Price Quote

$9.92
-0.68 (-6.42%)
(Updated: November 14, 2024 at 5:55 PM ET)

Ocular Therapeutix Key Stats

Buy
72
Ocular Therapeutix (OCUL) is a Buy
Day range:
$10.60 - $11.12
52-week range:
$2.05 - $11.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
20.53
P/B ratio:
4.38%
Volume:
845K
Avg. volume:
1.2M
1-year change:
379.64%
Market cap:
$1.7B
Revenue:
$58.4M
EPS:
$-1.35

How Much Does Ocular Therapeutix Make?

Is Ocular Therapeutix Growing As A Company?

  • What Is Ocular Therapeutix's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Ocular Therapeutix's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Ocular Therapeutix Stock Price Performance

What Is Ocular Therapeutix 52-Week High & Low?

Ocular Therapeutix Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ocular Therapeutix?

  • How Much Debt Does Ocular Therapeutix Have?
    Total long term debt quarterly is $67.1M
  • How Much Cash Does Ocular Therapeutix Have?
    Cash and short term investments quarterly total is $459.7M
  • What Is Ocular Therapeutix’s Book Value Per Share?
    Book value per share is 2.43

Is Ocular Therapeutix Cash Flow Positive?

  • What Is OCUL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$88.9M
  • What Is Ocular Therapeutix’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $483.5M
  • What Is Ocular Therapeutix’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.7M

Ocular Therapeutix Return On Invested Capital

  • Is Management Doing A Good Job?
    OCUL return on invested capital is -56.45%
  • What Is Ocular Therapeutix Return On Assets?
    ROA measures how assets are converting to revenues and is -43.43%
  • What Is OCUL Return On Equity?
    ROE is a measure of profitability and is -77.93%

Ocular Therapeutix Earnings Date & Stock Price

Ocular Therapeutix Competitors

  • Who Are Ocular Therapeutix's Competitors?
    Below is a list of companies who compete with Ocular Therapeutix or are related in some way:
    • 4D Molecular Therapeutics Inc (FDMT)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Ocular Therapeutix Dividend Yield

Ocular Therapeutix Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -21.88%
Revenue: 8.26% 3.75%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 16.56
Upside from Last Price: 56.18%

Major Shareholders

  • How many OCUL shares are owned by institutional investors?
    184.2M OCUL shares are owned by institutional investors
  • How many OCUL shares are owned by insiders?
    4.9M OCUL shares are owned by insiders